世界の核医学治療市場レポート2020年

【英語タイトル】Global Therapeutic Nuclear Medicines Sales Market Report 2020

QYResearchが出版した調査資料(QYR21FB14807)・商品コード:QYR21FB14807
・発行会社(調査会社):QYResearch
・発行日:2021年1月(※2024年版があります。お問い合わせください)
・ページ数:148
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界の核医学治療市場について種類別(ラジウム-223、ルテチウム-177、ヨウ素-131、その他)、用途別(甲状腺、骨転移、リンパ腫、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・核医学治療市場の概要
・世界の主要地域別核医学治療市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の核医学治療市場規模2015-2026:種類別(ラジウム-223、ルテチウム-177、ヨウ素-131、その他)
・世界の核医学治療市場規模2015-2026:用途別(甲状腺、骨転移、リンパ腫、その他)
・核医学治療のアメリカ市場規模2015-2020
・核医学治療のヨーロッパ市場規模2015-2020
・核医学治療の中国市場規模2015-2020
・核医学治療の日本市場規模2015-2020
・核医学治療の東南アジア市場規模2015-2020
・核医学治療のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・核医学治療の製造コスト分析
・販売チャネル、流通業者、顧客
・核医学治療の市場動向・機会・課題
・調査の結論
【レポートの概要】

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Market Analysis and Insights: Global Therapeutic Nuclear Medicines Market
The global Therapeutic Nuclear Medicines market size is projected to reach US$ 2473.9 million by 2026, from US$ 1139 million in 2020, at a CAGR of 13.8% during 2021-2026.

Global Therapeutic Nuclear Medicines Scope and Market Size
The global Therapeutic Nuclear Medicines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Nuclear Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Therapeutic Nuclear Medicines market is segmented into
Radium-223
Lutetium-177
Iodine-131
Other

Segment by Application, the Therapeutic Nuclear Medicines market is segmented into
Thyroid
Bone Metastasis
Lymphoma
Other

The Therapeutic Nuclear Medicines market is analysed and market size information is provided by regions (countries). Segment by Application, the Therapeutic Nuclear Medicines market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Therapeutic Nuclear Medicines Market Share Analysis
Therapeutic Nuclear Medicines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Therapeutic Nuclear Medicines business, the date to enter into the Therapeutic Nuclear Medicines market, Therapeutic Nuclear Medicines product introduction, recent developments, etc.

The major vendors covered:
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes

【レポートの目次】

1 Therapeutic Nuclear Medicines Market Overview
1.1 Therapeutic Nuclear Medicines Product Scope
1.2 Therapeutic Nuclear Medicines Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Sales by Type (2020-2026)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Therapeutic Nuclear Medicines Segment by Application
1.3.1 Global Therapeutic Nuclear Medicines Sales Comparison by Application (2020-2026)
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Therapeutic Nuclear Medicines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Therapeutic Nuclear Medicines Sales Growth Rate (2015-2026)
1.4.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2015-2026)
1.4.3 Global Therapeutic Nuclear Medicines Price Trends (2015-2026)

2 Therapeutic Nuclear Medicines Estimate and Forecast by Region
2.1 Global Therapeutic Nuclear Medicines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Therapeutic Nuclear Medicines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Therapeutic Nuclear Medicines Sales Market Share by Region (2015-2020)
2.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2015-2020)
2.3 Global Therapeutic Nuclear Medicines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Therapeutic Nuclear Medicines Estimates and Projections (2015-2026)
2.4.2 Europe Therapeutic Nuclear Medicines Estimates and Projections (2015-2026)
2.4.3 China Therapeutic Nuclear Medicines Estimates and Projections (2015-2026)
2.4.4 Japan Therapeutic Nuclear Medicines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Therapeutic Nuclear Medicines Estimates and Projections (2015-2026)
2.4.6 India Therapeutic Nuclear Medicines Estimates and Projections (2015-2026)
3 Global Therapeutic Nuclear Medicines Competition Landscape by Players
3.1 Global Top Therapeutic Nuclear Medicines Players by Sales (2015-2020)
3.2 Global Top Therapeutic Nuclear Medicines Players by Revenue (2015-2020)
3.3 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Nuclear Medicines as of 2019)
3.4 Global Therapeutic Nuclear Medicines Average Price by Company (2015-2020)
3.5 Manufacturers Therapeutic Nuclear Medicines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Therapeutic Nuclear Medicines Players (Opinion Leaders)
4 Global Therapeutic Nuclear Medicines Market Size by Type
4.1 Global Therapeutic Nuclear Medicines Historic Market Review by Type (2015-2020)
4.1.1 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
4.1.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2015-2020)
4.1.3 Global Therapeutic Nuclear Medicines Price by Type (2015-2020)
4.2 Global Therapeutic Nuclear Medicines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2021-2026)
4.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2021-2026)
4.2.3 Global Therapeutic Nuclear Medicines Price Forecast by Type (2021-2026)
5 Global Therapeutic Nuclear Medicines Market Size by Application
5.1 Global Therapeutic Nuclear Medicines Historic Market Review by Application (2015-2020)
5.1.1 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)
5.1.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2015-2020)
5.1.3 Global Therapeutic Nuclear Medicines Price by Application (2015-2020)
5.2 Global Therapeutic Nuclear Medicines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Therapeutic Nuclear Medicines Sales Forecast by Application (2021-2026)
5.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Application (2021-2026)
5.2.3 Global Therapeutic Nuclear Medicines Price Forecast by Application (2021-2026)

6 United States Therapeutic Nuclear Medicines Market Facts & Figures
6.1 United States Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
6.2 United States Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
6.3 United States Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)

7 Europe Therapeutic Nuclear Medicines Market Facts & Figures
7.1 Europe Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
7.2 Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
7.3 Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)

8 China Therapeutic Nuclear Medicines Market Facts & Figures
8.1 China Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
8.2 China Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
8.3 China Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)

9 Japan Therapeutic Nuclear Medicines Market Facts & Figures
9.1 Japan Therapeutic Nuclear Medicines Sales Market Share by Company (3015-3030)
9.2 Japan Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
9.3 Japan Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)

10 Southeast Asia Therapeutic Nuclear Medicines Market Facts & Figures
10.1 Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)

11 India Therapeutic Nuclear Medicines Market Facts & Figures
11.1 India Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
11.2 India Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
11.3 India Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Therapeutic Nuclear Medicines Business
12.1 Novartis AG
12.1.1 Novartis AG Corporation Information
12.1.2 Novartis AG Business Overview
12.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis AG Therapeutic Nuclear Medicines Products Offered
12.1.5 Novartis AG Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Therapeutic Nuclear Medicines Products Offered
12.2.5 Bayer Recent Development
12.3 China Isotope & Radiation
12.3.1 China Isotope & Radiation Corporation Information
12.3.2 China Isotope & Radiation Business Overview
12.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Products Offered
12.3.5 China Isotope & Radiation Recent Development
12.4 Q BioMed
12.4.1 Q BioMed Corporation Information
12.4.2 Q BioMed Business Overview
12.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Q BioMed Therapeutic Nuclear Medicines Products Offered
12.4.5 Q BioMed Recent Development
12.5 Curium Pharmaceuticals
12.5.1 Curium Pharmaceuticals Corporation Information
12.5.2 Curium Pharmaceuticals Business Overview
12.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Products Offered
12.5.5 Curium Pharmaceuticals Recent Development
12.6 Jubilant DraxImage
12.6.1 Jubilant DraxImage Corporation Information
12.6.2 Jubilant DraxImage Business Overview
12.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Products Offered
12.6.5 Jubilant DraxImage Recent Development
12.7 Dongcheng
12.7.1 Dongcheng Corporation Information
12.7.2 Dongcheng Business Overview
12.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dongcheng Therapeutic Nuclear Medicines Products Offered
12.7.5 Dongcheng Recent Development
12.8 Lantheus
12.8.1 Lantheus Corporation Information
12.8.2 Lantheus Business Overview
12.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Lantheus Therapeutic Nuclear Medicines Products Offered
12.8.5 Lantheus Recent Development
12.9 Acrotech Biopharma.
12.9.1 Acrotech Biopharma. Corporation Information
12.9.2 Acrotech Biopharma. Business Overview
12.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Products Offered
12.9.5 Acrotech Biopharma. Recent Development
12.10 Progenics Pharmaceuticals
12.10.1 Progenics Pharmaceuticals Corporation Information
12.10.2 Progenics Pharmaceuticals Business Overview
12.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Products Offered
12.10.5 Progenics Pharmaceuticals Recent Development
12.11 International Isotopes
12.11.1 International Isotopes Corporation Information
12.11.2 International Isotopes Business Overview
12.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 International Isotopes Therapeutic Nuclear Medicines Products Offered
12.11.5 International Isotopes Recent Development

13 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
13.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
13.4 Therapeutic Nuclear Medicines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Therapeutic Nuclear Medicines Distributors List
14.3 Therapeutic Nuclear Medicines Customers

15 Market Dynamics
15.1 Therapeutic Nuclear Medicines Market Trends
15.2 Therapeutic Nuclear Medicines Opportunities and Drivers
15.3 Therapeutic Nuclear Medicines Market Challenges
15.4 Therapeutic Nuclear Medicines Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Therapeutic Nuclear Medicines Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Therapeutic Nuclear Medicines Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Therapeutic Nuclear Medicines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Therapeutic Nuclear Medicines Sales (K Units) by Region (2015-2020)
Table 5. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2015-2020)
Table 6. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Therapeutic Nuclear Medicines Revenue Share by Region (2015-2020)
Table 8. Global Therapeutic Nuclear Medicines Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Therapeutic Nuclear Medicines Revenue Share Forecast by Region (2021-2026)
Table 12. Global Therapeutic Nuclear Medicines (K Units) of Key Companies (2015-2020)
Table 13. Global Therapeutic Nuclear Medicines Sales Share by Company (2015-2020)
Table 14. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Therapeutic Nuclear Medicines Revenue Share by Company (2015-2020)
Table 16. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Nuclear Medicines as of 2019)
Table 17. Global Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Therapeutic Nuclear Medicines Manufacturing Sites and Area Served
Table 19. Manufacturers Therapeutic Nuclear Medicines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Therapeutic Nuclear Medicines Players
Table 22. Global Therapeutic Nuclear Medicines Sales (K Units) by Type (2015-2020)
Table 23. Global Therapeutic Nuclear Medicines Sales Share by Type (2015-2020)
Table 24. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Therapeutic Nuclear Medicines Price (K Units) by Type (2015-2020)
Table 26. Global Therapeutic Nuclear Medicines Sales Share by Type (2021-2026)
Table 27. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Therapeutic Nuclear Medicines Revenue Share by Type (2021-2026)
Table 29. Global Therapeutic Nuclear Medicines Price (K Units) by Type (2021-2026)
Table 30. Global Therapeutic Nuclear Medicines Sales (K Units) by Application (2015-2020)
Table 31. Global Therapeutic Nuclear Medicines Sales Share by Application (2015-2020)
Table 32. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Therapeutic Nuclear Medicines Price (K Units) by Application (2015-2020)
Table 34. Global Therapeutic Nuclear Medicines Sales (K Units) by Application (2021-2026)
Table 35. Global Therapeutic Nuclear Medicines Sales Share by Application (2021-2026)
Table 36. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Therapeutic Nuclear Medicines Revenue Share by Application (2021-2026)
Table 38. Global Therapeutic Nuclear Medicines Price (K Units) by Application (2021-2026)
Table 39. United States Therapeutic Nuclear Medicines Sales (K Units) by Company (2015-2020)
Table 40. United States Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
Table 41. United States Therapeutic Nuclear Medicines Sales (K Units) by Type (2015-2020)
Table 42. United States Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 43. United States Therapeutic Nuclear Medicines Sales (K Units) by Application (2015-2020)
Table 44. United States Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 45. Europe Therapeutic Nuclear Medicines Sales (K Units) by Company (2015-2020)
Table 46. Europe Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
Table 47. Europe Therapeutic Nuclear Medicines Sales (K Units) by Type (2015-2020)
Table 48. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 49. Europe Therapeutic Nuclear Medicines Sales (K Units) by Application (2015-2020)
Table 50. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 51. China Therapeutic Nuclear Medicines Sales (K Units) by Company (2015-2020)
Table 52. China Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
Table 53. China Therapeutic Nuclear Medicines Sales (K Units) by Type (2015-2020)
Table 54. China Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 55. China Therapeutic Nuclear Medicines Sales (K Units) by Application (2015-2020)
Table 56. China Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 57. Japan Therapeutic Nuclear Medicines Sales (K Units) by Company (2015-2020)
Table 58. Japan Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
Table 59. Japan Therapeutic Nuclear Medicines Sales (K Units) by Type (2015-2020)
Table 60. Japan Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 61. Japan Therapeutic Nuclear Medicines Sales (K Units) by Application (2015-2020)
Table 62. Japan Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Therapeutic Nuclear Medicines Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Therapeutic Nuclear Medicines Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Therapeutic Nuclear Medicines Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 69. India Therapeutic Nuclear Medicines Sales (K Units) by Company (2015-2020)
Table 70. India Therapeutic Nuclear Medicines Sales Market Share by Company (2015-2020)
Table 71. India Therapeutic Nuclear Medicines Sales (K Units) by Type (2015-2020)
Table 72. India Therapeutic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 73. India Therapeutic Nuclear Medicines Sales (K Units) by Application (2015-2020)
Table 74. India Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 75. Novartis AG Corporation Information
Table 76. Novartis AG Description and Business Overview
Table 77. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Novartis AG Therapeutic Nuclear Medicines Product
Table 79. Novartis AG Recent Development
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Bayer Therapeutic Nuclear Medicines Product
Table 84. Bayer Recent Development
Table 85. China Isotope & Radiation Corporation Information
Table 86. China Isotope & Radiation Description and Business Overview
Table 87. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. China Isotope & Radiation Therapeutic Nuclear Medicines Product
Table 89. China Isotope & Radiation Recent Development
Table 90. Q BioMed Corporation Information
Table 91. Q BioMed Description and Business Overview
Table 92. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Q BioMed Therapeutic Nuclear Medicines Product
Table 94. Q BioMed Recent Development
Table 95. Curium Pharmaceuticals Corporation Information
Table 96. Curium Pharmaceuticals Description and Business Overview
Table 97. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product
Table 99. Curium Pharmaceuticals Recent Development
Table 100. Jubilant DraxImage Corporation Information
Table 101. Jubilant DraxImage Description and Business Overview
Table 102. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Jubilant DraxImage Therapeutic Nuclear Medicines Product
Table 104. Jubilant DraxImage Recent Development
Table 105. Dongcheng Corporation Information
Table 106. Dongcheng Description and Business Overview
Table 107. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Dongcheng Therapeutic Nuclear Medicines Product
Table 109. Dongcheng Recent Development
Table 110. Lantheus Corporation Information
Table 111. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Lantheus Description and Business Overview
Table 113. Lantheus Therapeutic Nuclear Medicines Product
Table 114. Lantheus Recent Development
Table 115. Acrotech Biopharma. Corporation Information
Table 116. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Acrotech Biopharma. Description and Business Overview
Table 118. Acrotech Biopharma. Therapeutic Nuclear Medicines Product
Table 119. Acrotech Biopharma. Recent Development
Table 120. Progenics Pharmaceuticals Corporation Information
Table 121. Progenics Pharmaceuticals Description and Business Overview
Table 122. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product
Table 124. Progenics Pharmaceuticals Recent Development
Table 125. International Isotopes Corporation Information
Table 126. International Isotopes Description and Business Overview
Table 127. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. International Isotopes Therapeutic Nuclear Medicines Product
Table 129. International Isotopes Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Therapeutic Nuclear Medicines Distributors List
Table 133. Therapeutic Nuclear Medicines Customers List
Table 134. Therapeutic Nuclear Medicines Market Key Trends
Table 135. Therapeutic Nuclear Medicines Key Opportunities and Drivers
Table 136. Therapeutic Nuclear Medicines Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Nuclear Medicines Product Picture
Figure 2. Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Therapeutic Nuclear Medicines Market Share by Application in 2020 & 2026
Figure 6. Thyroid Examples
Figure 7. Bone Metastasis Examples
Figure 8. Lymphoma Examples
Figure 9. Other Examples
Figure 10. Global Therapeutic Nuclear Medicines Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Therapeutic Nuclear Medicines Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Therapeutic Nuclear Medicines Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Therapeutic Nuclear Medicines Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Therapeutic Nuclear Medicines Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Therapeutic Nuclear Medicines Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Therapeutic Nuclear Medicines Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Therapeutic Nuclear Medicines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Therapeutic Nuclear Medicines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Therapeutic Nuclear Medicines Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Therapeutic Nuclear Medicines Players Market Share by Revenue in Therapeutic Nuclear Medicines 2015 & 2019
Figure 28. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Therapeutic Nuclear Medicines Revenue Share by Type (2015-2020)
Figure 30. Global Therapeutic Nuclear Medicines Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Therapeutic Nuclear Medicines Revenue Share by Application (2015-2020)
Figure 32. Global Therapeutic Nuclear Medicines Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Therapeutic Nuclear Medicines Sales Market Share by Type in 2019
Figure 34. United States Therapeutic Nuclear Medicines Sales Market Share by Type in 2019
Figure 35. Europe Therapeutic Nuclear Medicines Sales Market Share by Company in 2019
Figure 36. Europe Therapeutic Nuclear Medicines Sales Market Share by Type in 2019
Figure 37. Europe Therapeutic Nuclear Medicines Sales Market Share by Application in 2019
Figure 38. China Therapeutic Nuclear Medicines Sales Market Share by Company in 2019
Figure 39. China Therapeutic Nuclear Medicines Sales Market Share by Type in 2019
Figure 40. China Therapeutic Nuclear Medicines Sales Market Share by Application in 2019
Figure 41. Japan Therapeutic Nuclear Medicines Sales Market Share by Company in 2019
Figure 42. Japan Therapeutic Nuclear Medicines Sales Market Share by Type in 2019
Figure 43. Japan Therapeutic Nuclear Medicines Sales Market Share by Application in 2019
Figure 44. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Company in 2019
Figure 45. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Type in 2019
Figure 46. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Application in 2019
Figure 47. India Therapeutic Nuclear Medicines Sales Market Share by Company in 2019
Figure 48. India Therapeutic Nuclear Medicines Sales Market Share by Type in 2019
Figure 49. India Therapeutic Nuclear Medicines Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure 52. Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure 53. Therapeutic Nuclear Medicines Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


【掲載企業】

Novartis AG、Bayer、China Isotope & Radiation、Q BioMed、Curium Pharmaceuticals、Jubilant DraxImage、Dongcheng、Lantheus、Acrotech Biopharma.、Progenics Pharmaceuticals、International Isotopes

★調査レポート[世界の核医学治療市場レポート2020年] (コード:QYR21FB14807)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の核医学治療市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆